Literature DB >> 1689531

Pathological changes in cystic craniopharyngiomas following intracavital 90yttrium treatment.

G T Szeifert1, J Julow, F Slowik, K Bálint, F Lányi, E Pásztor.   

Abstract

Radiosurgery, using 90Y injected directly into the cavity of cystic craniopharyngiomas produces remarkable reduction of tumour size and diminishes cyst fluid production. The authors have studied the histology of biopsy and autopsy material obtained from seven patients presented with cystic craniopharyngiomas. Histological examination was carried out before and after 90Y silicate implantation. As an effect of 90Y irradiation, histology of samples taken from the cyst wall revealed that the lining epithelial cell layer became destroyed and the cyst wall shrunk. Large amount of collagen fibres with focal hyaline degeneration was present. Proliferation of intimal cells and subendothelial connective tissue narrowing small vessel lumina also occurred. Considering that fibrotic tissue is more susceptible to shrink, the fibrosis induced by irradiation together with destruction of the squamous epithelium and vascular changes, might explain the reduction of the cyst volume and diminished fluid secretion after 90Y treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689531     DOI: 10.1007/bf01402179

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  13 in total

1.  Craniopharyngiomas. Treatment by combined surgery and radiation therapy.

Authors:  S KRAMER; W MCKISSOCK; J P CONCANNON
Journal:  J Neurosurg       Date:  1961-03       Impact factor: 5.115

2.  Treatment of craniopharyngiomas--the stereotactic approach in a ten to twenty-three years' perspective. I. Surgical, radiological and ophthalmological aspects.

Authors:  E O Backlund; B Axelsson; C G Bergstrand; A L Eriksson; G Norén; E Ribbesjö; T Rähn; P O Schnell; L Tallstedt; M Sääf
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

3.  Selective staining of human dermal collagen. II. The use of picrosirius red F3BA with polarization microscopy.

Authors:  V S Constantine; R W Mowry
Journal:  J Invest Dermatol       Date:  1968-05       Impact factor: 8.551

4.  Treatment of craniopharyngiomas.

Authors:  L Leksell; E O Backlund; L Johansson
Journal:  Acta Chir Scand       Date:  1967

5.  Radical excision of craniopharyngioma. Results in 20 patients.

Authors:  L Symon; W Sprich
Journal:  J Neurosurg       Date:  1985-02       Impact factor: 5.115

6.  Pathological and clinical basis of the indications for treatment of craniopharyngiomas.

Authors:  T Kobayashi; N Kageyama; J Yoshida; N Shibuya; T Yonezawa
Journal:  Neurol Med Chir (Tokyo)       Date:  1981-01       Impact factor: 1.742

7.  Recurrent craniopharyngiomas: therapeutic alternatives.

Authors:  W H Sweet
Journal:  Clin Neurosurg       Date:  1980

8.  Radioisotope therapy of cystic craniopharyngomas.

Authors:  L Strauss; V Sturm; P Georgi; W Schlegel; H Ostertag; J H Clorius; G van Kaick
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-09       Impact factor: 7.038

9.  The radiotherapy of cystic craniopharyngioma with intracystic installation of 90Y silicate colloid.

Authors:  J Julow; F Lányi; M Hajda; M Simkovics; I Arany; S Tóth; E Pásztor
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

10.  Recurrent cystic craniopharyngioma management and course.

Authors:  G Polz-Tejera; L Sod; D Kotsilimbas
Journal:  Neurochirurgia (Stuttg)       Date:  1986-03
View more
  5 in total

Review 1.  Intracavitary therapeutic options in the management of cystic craniopharyngioma.

Authors:  Adrián Cáceres
Journal:  Childs Nerv Syst       Date:  2005-07-19       Impact factor: 1.475

Review 2.  Radiotherapy of other sellar lesions.

Authors:  N Karavitaki
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

3.  Intracavitary treatment of intrasellar cystic craniopharyngeomas with 90-Yttrium by trans-sphenoidal approach--a technical note.

Authors:  M Lange; C M Kirsch; U Steude; R Oeckler
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

Review 4.  Use of antibodies and immunoconjugates for the therapy of more accessible cancers.

Authors:  Robert M Sharkey; David M Goldenberg
Journal:  Adv Drug Deliv Rev       Date:  2008-04-24       Impact factor: 15.470

5.  Intracystic irradiation for craniopharyngiomas.

Authors:  Jenő Viktor Julow
Journal:  Pituitary       Date:  2013-03       Impact factor: 4.107

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.